Zydus Wellness shares rise nearly 9% after announcing Comfort Click acquisition in UK

Shares of Zydus Wellness, the Ahmedabad-based packaged foods company, gained nearly 9% on Monday to hit a high of ₹2,197.50 after the company announced its first overseas acquisition.

The firm said its wholly owned subsidiary, Alidac UK Ltd, has entered into a definitive agreement to acquire Comfort Click Ltd (CCL), a UK-headquartered company with subsidiaries in Ireland, United States and India. The deal, valued at 239 million pounds (about ₹2,846 crore), remains subject to customary closing conditions and adjustments under the terms of the Share Purchase Agreement.

This transaction marks Zydus Wellness’ entry into the Vitamins, Minerals and Supplements (VMS) market. Comfort Click, which has operations across UK and European markets, reported unaudited revenues of 134 million pounds for the year ended June 30, 2025, with a five-year CAGR of 57%. Its adjusted operating profit stood at GBP 21 million.

At the time of writing this article, shares of Zydus Wellness were trading 7.20% higher at ₹2,164 apiece on the National Stock Exchange (NSE). The company’s total market capitalisation stands at ₹13,763.63 crore as of September 1. Shares of Zydus Wellness touched its 52 week high of around ₹2,484 on July 30, 2024 and its 52-week low of approximately ₹1,493 on March 4, 2025.

“The global acquisition of Comfort Click, a leading player in the digital vitamins, minerals and supplements space, marks a significant step in our journey to empower consumers to make informed choices and embrace wellness focused products as part of their path to better health. This strategic move reflects our aspiration to be a forward-looking company that not only anticipates consumer needs but also enables easy access to them. With Comfort Click, we are strengthening our global capabilities, deepening our presence in digital health and personal wellness, and exploring scalable and sustainable models that will shape the future of wellbeing. We are excited and exploring new possibilities driven by innovation and a customer first approach,” said Dr. Sharvil Patel, Chairman, Zydus Wellness.

Tarun Arora, CEO and Whole-Time Director, Zydus Wellness Limited, said “The acquisition of Comfort Click is a significant step forward in our journey to strengthen our leadership in the wellness space. It aligns with our strategic vision of expanding Zydus Wellness’ international footprint while deepening our capabilities in consumer-centric health and wellbeing solutions.

Zydus Wellness Q1 results:

Zydus Wellness reported the consolidated net profit increased 3% year-on-year (YoY) to ₹1,467 crore in the first quarter of FY26, riding on strong performance across domestic and international markets. The drug maker has posted a net profit of ₹1,420 crore in the June quarter of the previous fiscal year. Its revenue from operations rose 5.91% YoY to ₹6,574 crore during the quarter under review, compared to ₹6,207 crore in the year-ago period, the company said in a statement.

The maker of Complan and Glucon-D said its domestic business revenue increased 6% YoY to ₹2,374 crore during the reporting quarter, compared to ₹2,243.9 crore. Its revenue from the formulations business saw a growth of 8% YoY to ₹1,519 crore in Q1FY26, as against ₹1,407.3 crore in the year-ago period.

The company’s consumer wellness business revenue grew 2% YoY to ₹855 crore in the first quarter ended June 30, 2025. Its US formulations business revenue grew 3% YoY to ₹3,182 crore in the June quarter.

At an operational level, its EBITDA (earnings before interest, tax, depreciation and amortisation) remained stable at ₹2,089 crore. Its EBITDA margin shrank 200 basis points to 31.8% in Q1FY26, as against 29.6% in the first quarter of FY25.